IPO7

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, IPO7 mutation is significantly associated with the RNA expression of many other genes, with 3,836 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible IPO7-associated genes across cancer lineages are LINC00410, SLC36A1, and NPAP1P7. Each is linked with IPO7 in more than 2 cancer types. Because this analysis shows association rather than direction, both IPO7-to-partner and partner-to-IPO7 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (IPO7→partner) and Y-score (partner→IPO7) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LUADLINC00410 →+0.134+4.568.001.00433
UCECSLC36A1 →+0.463+1.748<.001.00233
LIHCNPAP1P7 →+0.030+5.676<.001.00132
CESCGJE1 →+0.037+3.475<.001.00832
CESCCCDC12P1 →+0.059+4.342<.001.00732
HNSCTRAJ28 →+0.347+2.940.001.00632
Each partner links to its Q-omics profile. Showing the 6 strongest of 3,836 associations by consensus.

Exploration